Manufacturing
AI Score 78/100

Established Swiss Precision Manufacturing Leader in Medtech & Aerospace, Succession Ready

St. Gallen

Availability unverified since 23 August 2026. The source portal blocks our checks; confirm with us before relying on it.

Annual revenue
CHF 2M – 5M
EBITDA margin
Not disclosed
Employees
11 – 20
Asking price
Sign in to view

About this business

This is a high-quality precision manufacturing business in regulated sectors (medtech, aerospace, defence) with strong margins, stable long-term customer contracts, and operational continuity secured through management retention. The asking price of CHF 4.6M represents a reasonable 4.8x EBITDA multiple on estimated CHF 950K EBITDA (assuming mid-range 31-32% EBITDA margin), though St. Gallen's moderate tax environment and secondary economic ranking slightly offset the attractive fundamentals. Score: 78/100, Industry: 22/25, Pricing: 16/25, Geography: 12/20, Urgency: 14/15, Quality: 14/15 --- Entreprise de précision de haute qualité dans les secteurs réglementés (medtech, aérospatiale, défense) avec des marges solides, des contrats clients stables à long terme et la continuité opérationnelle assurée par la rétention de la direction. Le prix demandé de CHF 4,6 M représente un multiple EBITDA raisonnable de 4,8x sur l'EBITDA estimé à CHF 950K (en supposant une marge EBITDA de 31-32%), bien que l'environnement fiscal modéré de Saint-Gall et le classement économique secondaire compensent légèrement les fondamentaux attrayants.

Full description available after signup.

Sale & handover

Handover terms and reason for sale available after signup.

Highlights & considerationsAI-compiled

Growth opportunities

  • →Geographic expansion within Europe and regulated markets
  • →New product development in adjacent precision manufacturing domains
  • →Capacity scaling to serve growth in existing customer base
  • →Expansion into new regulated industries (e.g., medical device subcategories)
  • →Digital transformation and Industry 4.0 adoption
  • →Acquisition roll up strategy to consolidate regional competitors
  • →Export market development in aerospace and defence sectors

Key assets

  • ·Precision manufacturing capabilities (forming, milling, turning, grinding/polishing)
  • ·Proprietary measurement and quality control systems
  • ·Long term stable customer contracts
  • ·Established reputation in regulated industries (medical, aerospace, defence)
  • ·Experienced operations team with knowledge transfer potential
  • ·High equity capitalization
  • ·Strong cash generation
  • ·ISO certified quality systems (implied by regulated market focus)

Considerations

  • ·Key person dependency on owner/operations manager
  • ·Customer concentration (likely dependent on few large contracts in regulated sectors)
  • ·Regulatory risk exposure across medical, aerospace, and defence sectors
  • ·Technology obsolescence risk in precision manufacturing
  • ·High competition in precision manufacturing space
  • ·Limited organic growth trajectory given stable (not growing) revenue
  • ·Transition execution risk despite planned continuity measures

Compiled by Alpine Business from the listing and public sources. Verify all points during due diligence.

What you'll see after signing the NDA

  • → Exact revenue, EBITDA, and asking price
  • → Full business description and operational details
  • → Seller contact information
  • → Customer concentration and key revenue sources
  • → Reason for sale and ideal buyer profile
  • → Direct introduction to the seller
  • → Request further documentation through Alpine

Confidential. Legally binding under Swiss law. Free.

Similar businesses for sale